Malignant reversion of a human osteosarcoma cell line, saos-2, by inhibition of NFκB

Valentine B. Andela, Tzong Jen Sheu, Edward J. Puzas, Edward M. Schwarz, Regis J. O'Keefe, Randy N. Rosier

Research output: Contribution to journalArticle

33 Scopus citations

Abstract

Beyond a pivotal role in neoplastic transformation and malignant progression, NFκB is intricately involved in bone biology, pointed up by the osteopetrotic phenotype of NFκB (p50-p52) double knock-out mice. Osteopetrosis results from intrinsic defects in osteoclastogenesis, loss of osteoclast bone resorptive activity and, questionably, increased osteoblast activity (bone matrix apposition and mineralization). We here report that inhibition of NFκB signaling activity in Saos-2 cells results in a marked decrease in cellular proliferation, assessed by the incorporation of radioactive thymidine into cellular DNA. Decreased cellular proliferation was accompanied by the induction of bone morphogenic proteins (BMP) 4, 7, and the osteoblast specific transciption factor, Cbfa1, heralding osteoblast differentiation, given the induction of alkaline phosphatase, osteopontin, and osteocalcin message levels and the attendant increase in matrix deposition and mineralization in vitro. These results point to the negative regulation of osteoblast differentiation by NFκB, with implications in the pathogenesis and progression of osteosarcomas.

Original languageEnglish
Pages (from-to)237-241
Number of pages5
JournalBiochemical and Biophysical Research Communications
Volume297
Issue number2
DOIs
StatePublished - Nov 6 2002
Externally publishedYes

Keywords

  • BMPs
  • Cbfa-1
  • Differentiation
  • NFκB
  • Osteoblasts
  • Osteosarcoma
  • Proliferation
  • Rb

Fingerprint Dive into the research topics of 'Malignant reversion of a human osteosarcoma cell line, saos-2, by inhibition of NFκB'. Together they form a unique fingerprint.

  • Cite this